Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cooper J. F., Foti A., Herschman H. Combined serum and bone marrow radioimmunoassays for prostatic acid phosphatase. J Urol. 1979 Oct;122(4):498–502. doi: 10.1016/s0022-5347(17)56480-0. [DOI] [PubMed] [Google Scholar]
- Hovsepian J. A., Byar D. P. Carcinoma of prostate. Correlation between radiologic quantitation of metastases and patient survival. Urology. 1975 Jul;6(1):11–16. doi: 10.1016/0090-4295(75)90584-1. [DOI] [PubMed] [Google Scholar]
- Kvols L. K., Eagan R. T., Myers R. P. Evaluation of melphalan, ICRF-159, and hydroxyurea in metastatic prostate cancer: a preliminary report. Cancer Treat Rep. 1977 Mar-Apr;61(2):311–312. [PubMed] [Google Scholar]
- Merrin C., Etra W., Wajsman Z., Baumgartner G., Murphy G. Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin. J Urol. 1976 Jan;115(1):86–88. doi: 10.1016/s0022-5347(17)59077-1. [DOI] [PubMed] [Google Scholar]
- Paulson D. F., Berry W. R., Cox E. B., Walker A., Laszlo J. Treatment of metastatic endocrine-unresponsive carcinoma of the prostate gland with multiagent chemotherapy: indicators of response to therapy. J Natl Cancer Inst. 1979 Sep;63(3):615–622. doi: 10.1093/jnci/63.3.615. [DOI] [PubMed] [Google Scholar]
- Pontes J. E., Choe B., Rose N., Pierce J. M., Jr Reliability of bone marrow acid phosphatase as a parameter of metastatic prostatic cancer. J Urol. 1979 Aug;122(2):178–179. doi: 10.1016/s0022-5347(17)56314-4. [DOI] [PubMed] [Google Scholar]